Circulating Small Noncoding RNA Profiling as a Potential Biomarker of Atherosclerotic Plaque Composition in Type 1 Diabetes

• Published in: Diabetes care Vol. 46; no. 3; pp. 551 - 560
• Main Authors: Giannella, Alessandra, Castelblanco, Esmeralda, Zambon, Carlo Federico, Basso, Daniela, Hernandez, Marta, Ortega, Emilio, Alonso, Nuria, Mauricio, Didac, Avogaro, Angelo, Ceolotto, Giulio, Vigili de Kreutzenberg, Saula
• Format: Journal Article
• Language: English
• Published: United States American Diabetes Association 01.03.2023
• Subjects: Apoptosis; Arteriosclerosis; Atherosclerosis; Biomarkers; Calcification; Calcification (ectopic); Cardiovascular diseases; Cholesterol; Composition; Diabetes; Diabetes mellitus; Diabetes mellitus (insulin dependent); Diabetes Mellitus, Type 1 - genetics; Differentiation (biology); Extracellular matrix; Gene expression; Heart diseases; Humans; Lipid metabolism; Low density lipoprotein; MicroRNAs; MicroRNAs - genetics; miRNA; Next-generation sequencing; Original; Osteogenesis; Phenotypes; Plaque, Atherosclerotic; Research design; RNA, Small Untranslated
• ISSN: 0149-5992; 1935-5548; 1935-5548
• DOI: 10.2337/dc22-1441

Cardiovascular disease (CVD) accounts for most deaths in patients with type 1 diabetes (T1D); however, the determinants of plaque composition are unknown. miRNAs regulate gene expression, participate in the development of atherosclerosis, and represent promising CVD biomarkers. This study analyzed the circulating miRNA expression profile in T1D with either carotid calcified (CCP) or fibrous plaque (CFP). Circulating small noncoding RNAs were sequenced and quantified using next-generation sequencing and bioinformatic analysis in an exploratory set of 26 subjects with T1D with CCP and in 25 with CFP. Then, in a validation set of 40 subjects with CCP, 40 with CFP, and 24 control subjects with T1D, selected miRNA expression was measured by digital droplet PCR. Putative gene targets enriched for pathways implicated in atherosclerosis/vascular calcification/diabetes were analyzed. The patients' main clinical characteristics were also recorded. miR-503-5p, let-7d-5p, miR-106b-3p, and miR-93-5p were significantly upregulated, while miR-10a-5p was downregulated in patients with CCP compared with CFP (all fold change >±1.5; P < 0.05). All candidate miRNAs showed a significant correlation with LDL-cholesterol, direct for the upregulated and inverse for the downregulated miRNA, in CCP. Many target genes of upregulated miRNAs in CCP participate in osteogenic differentiation, apoptosis, inflammation, cholesterol metabolism, and extracellular matrix organization. These findings characterize miRNAs and their signature in the regulatory network of carotid plaque phenotype in T1D, providing new insights into plaque pathophysiology and possibly novel biomarkers of plaque composition.